Mary Ross Southworth

Division of Cardiology and Nephrology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA, United States

Disclosure information not submitted.

Presentation(s):

• Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk

  Monday, August 26, 2024
  1:30 PM – 1:45 PM CEST